Pear Therapeutics, Inc. (“Pear Therapeutics”) is headquartered in Boston, MA. Our mailing address is 200 State Street, 13th floor, Boston, MA 02109. Pear Therapeutics (US), Inc. is the operating company of Pear Therapeutics, Inc. Pear has offices in Boston, MA, Raleigh, NC and San Francisco, CA.
8-K, quarterly and annual reports and other investor materials are available under the SEC Filings section of the website. Additionally, all SEC filings can also be viewed directly on the SEC website.
Pear Therapeutics will issue a press release that includes the date of our quarterly earnings call. These releases, which will be issued approximately 2 weeks prior to the corresponding calls, will be posted on the News and Press Releases section of our website, including the details for accessing the conference call and/or webcast to discuss the results.